Stephens & Co. analyst Andrew Terrell maintains Five Star Bancorp (NASDAQ:FSBC) with a Overweight and raises the price target from $30 to $31.
What’s Going On With Cadrenal Therapeutics Stock Today
The FDA has granted a Fast Track designation to Cadrenal Therapeutics Inc’s (NASDAQ:CVKD) tecarfarin for the prevention of systemic thromboembolism, more commonly…